Authors:
Quinton, R
Duke, VM
Robertson, A
Kirk, JMW
Matfin, G
de Zoysa, PA
Azcona, C
MacColl, GS
Jacobs, HS
Conway, GS
Besser, M
Stanhope, RG
Bouloux, PMG
Citation: R. Quinton et al., Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization, CLIN ENDOCR, 55(2), 2001, pp. 163-174
Citation: M. Elsheikh et al., Autoimmune thyroid syndrome in women with Turner's syndrome - the association with karyotype, CLIN ENDOCR, 55(2), 2001, pp. 223-226
Authors:
Elsheikh, M
Hodgson, HJF
Wass, JAH
Conway, GS
Citation: M. Elsheikh et al., Hormone replacement therapy may improve hepatic function in women with Turner's syndrome, CLIN ENDOCR, 55(2), 2001, pp. 227-231
Authors:
Elsheikh, M
Casadei, B
Conway, GS
Wass, JAH
Citation: M. Elsheikh et al., Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome, CLIN ENDOCR, 54(1), 2001, pp. 69-73
Authors:
Quinton, R
Beirne, P
Bouloux, PMG
Stanhope, RG
Conway, GS
Citation: R. Quinton et al., Routine neuroimaging in classical isolated gonadotrophin deficiency is of limited clinical value, CLIN ENDOCR, 54(1), 2001, pp. 127-129
Authors:
Blackwell, VC
Salis, P
Groves, RW
Baldeweg, SE
Conway, GS
Unwin, RJ
Citation: Vc. Blackwell et al., Partial lipodystrophy, polycystic ovary syndrome and proteinuria: a commonlink to insulin resistance?, J ROY S MED, 94(5), 2001, pp. 238-240
Authors:
Saenger, P
Wikland, KA
Conway, GS
Davenport, M
Gravholt, CH
Hintz, R
Hovatta, O
Hultcrantz, M
Landin-Wilhelmsen, K
Lin, A
Lippe, B
Pasquino, AM
Ranke, MB
Rosenfeld, R
Silberbach, M
Citation: P. Saenger et al., Recommendations for the diagnosis and management of Turner syndrome, J CLIN END, 86(7), 2001, pp. 3061-3069
Citation: Rw. Davison et al., Mapping of the POF1 locus and identification of putative genes for premature ovarian failure, MOL HUM REP, 6(4), 2000, pp. 314-318
Authors:
Davis, CJ
Davison, RM
Payne, NN
Rodeck, CH
Conway, GS
Citation: Cj. Davis et al., Female sex preponderance for idiopathic familial premature ovarian failuresuggests an X chromosome defect, HUM REPR, 15(11), 2000, pp. 2418-2422
Authors:
Elsheikh, M
Bird, R
Casadei, B
Conway, GS
Wass, JAH
Citation: M. Elsheikh et al., The effect of hormone replacement therapy on cardiovascular hemodynamics in women with Turner's syndrome, J CLIN END, 85(2), 2000, pp. 614-618
Authors:
Agrawal, R
Prelevic, G
Conway, GS
Payne, NN
Ginsburg, J
Jacobs, HS
Citation: R. Agrawal et al., Serum vascular endothelial growth factor concentrations in postmenopausal women: the effect of hormone replacement therapy, FERT STERIL, 73(1), 2000, pp. 56-60
Authors:
Bareille, P
Azcona, C
Matthews, DR
Conway, GS
Stanhope, R
Citation: P. Bareille et al., Lipid profile, glucose tolerance and insulin sensitivity after more than four years of growth hormone therapy in non-growth hormone deficient adolescents, CLIN ENDOCR, 51(3), 1999, pp. 347-353
Authors:
Conway, GS
Conway, E
Walker, C
Hoppner, W
Gromoll, J
Simoni, M
Citation: Gs. Conway et al., Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome, CLIN ENDOCR, 51(1), 1999, pp. 97-99
Authors:
Agrawal, R
Conway, GS
Sladkevicius, P
Payne, NN
Bekir, J
Campbell, S
Tan, SL
Jacobs, HS
Citation: R. Agrawal et al., Serum vascular endothelial growth factor (VEGF) in the normal menstrual cycle: association with changes in ovarian and uterine Doppler blood flow, CLIN ENDOCR, 50(1), 1999, pp. 101-106
Authors:
Murray, A
Webb, J
MacSwiney, F
Shipley, EL
Morton, NE
Conway, GS
Citation: A. Murray et al., Serum concentrations of follicle stimulating hormone may predict prematureovarian failure in FRAXA premutation women, HUM REPR, 14(5), 1999, pp. 1217-1218
Citation: Jf. Morgan et al., Changes in plasma concentrations of leptin and body fat composition duringweight restoration in anorexia nervosa, J CLIN END, 84(6), 1999, pp. 2257-2257